| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.1B | $27.5B | $26.1B | $23.8B | $15.8B | $2.0B | $5.7B | $5.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.4B | $0.3B | $0.2B | $1.0B | $1.7B | $-1.2B | $0.7B | $0.8B |
| Net Income | $0.4B | $0.5B | $0.5B | $-0.2B | $1.0B | $-0.9B | $0.5B | $0.7B |
| EPS (Basic) | $0.82 | $0.78 | $0.78 | $0.91 | $1.65 | $-1.54 | $0.98 | $1.17 |
| EPS (Diluted) | $0.79 | $0.76 | $0.76 | $0.87 | $1.61 | $-1.54 | $0.98 | $1.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.1B | $33.8B | $36.5B | $35.4B | $36.3B | $34.6B | $25.9B | $26.2B |
| Current Assets | $5.6B | $11.3B | $14.0B | $14.8B | $18.0B | $15.2B | $6.0B | $5.0B |
| Cash & Equivalents | $3.2B | $7.5B | $9.3B | $9.5B | $12.5B | $11.1B | $2.5B | $1.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $10.9B | $12.3B | $12.3B | $10.4B | $9.2B | $7.5B | $9.0B | $7.9B |
| Stockholders' Equity | $8.0B | $10.3B | $10.5B | $10.7B | $10.4B | $8.9B | $9.8B | $9.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $0.5B | $3.2B | $3.8B | $2.3B | $-1.1B | $4.0B | $4.9B |
| Investing Cash Flow | $-1.4B | $-0.3B | $-2.9B | $-3.7B | $-1.3B | $-0.0B | $-0.3B | $-2.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.7B | $-2.0B | $-0.4B | $-3.0B | $0.4B | $9.7B | $-3.0B | $-2.5B |